hsa-mir-124
Showing 1 - 25 of 321
Cervical Intraepithelial Neoplasia Grade 2, DNA Methylation Trial in Maribor (Testing DNA methylation test for predicting
Recruiting
- Cervical Intraepithelial Neoplasia Grade 2
- DNA Methylation
- Testing DNA methylation test for predicting prognosis of untreated CIN 2
-
Maribor, SloveniaUniversity Medical Centre Maribor
Nov 14, 2022
Bipolar II Disorder, Most Recent Episode Major Depressive Trial in Kaohsiung city (repetitive transcranial magnetic stimulation
Recruiting
- Bipolar II Disorder, Most Recent Episode Major Depressive
- repetitive transcranial magnetic stimulation (rTMS)
- sham repetitive transcranial magnetic stimulation (rTMS)
-
Kaohsiung city, TaiwanKaohsiungVGH
Aug 16, 2022
Blood Biochemical Markers for Diagnostics of Heart Muscle
Active, not recruiting
- Heart Failure
- +2 more
- microRNA test
- Heart ultrasound examination
-
Ostrava-Poruba, Czech Republic, CzechiaUniversity Hospital Ostrava
Feb 9, 2023
Aging Trial in Keelung (Supervised exercise training, Aerobic exercise training)
Completed
- Aging
- Supervised exercise training
- Aerobic exercise training
-
Keelung, TaiwanKeelung Chang Gung Memorial Hospital
Jul 21, 2022
miR-200b & miR-21 in Diabetic Wounds
Recruiting
- Diabetes Mellitus
- +5 more
- No interventions
-
Indianapolis, IndianaIU Health Methodist Hospital
Mar 29, 2022
Recurrent Bladder Carcinoma, Bladder Cancer Stage 0, Bladder Cancer Stage I Trial in Los Angeles (Pharmacokinetic Study,
Not yet recruiting
- Recurrent Bladder Carcinoma
- +2 more
- Pharmacokinetic Study
- Recombinant EphB4-HSA Fusion Protein
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Jan 31, 2023
Stage IV Bladder Urothelial Carcinoma, Prostate Cancer, Urothelial Carcinoma Trial in United States (procedure, other,
Recruiting
- Stage IV Bladder Urothelial Carcinoma
- +2 more
- Computed Tomography
- +4 more
-
Duarte, California
- +8 more
Nov 19, 2022
Skin Kaposi Sarcoma Trial in United States (other, behavioral, biological)
Recruiting
- Skin Kaposi Sarcoma
- Laboratory Biomarker Analysis
- +3 more
-
La Jolla, California
- +9 more
Jun 22, 2022
Myocardial Infarction, Acute Trial in Cairo (No intervention)
Completed
- Myocardial Infarction, Acute
- No intervention
-
Cairo, EgyptBiochemistry Department, Faculty of Pharmacy and Biotechnology,
Jan 18, 2023
Breast Carcinoma, Endometrial Carcinoma, Prostate Carcinosarcoma Trial in Philadelphia (dietary supplement, other, procedure)
Completed
- Breast Carcinoma
- +2 more
- Dietary Intervention
- +2 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Jan 4, 2023
Urinary Exosome in Type 2 Diabetic Kidney Disease and Evaluation
Active, not recruiting
- Diabetic Nephropathy
- Grouping based on previous laboratory results, no intervention.
-
Jinan, Shandong, ChinaQianfoshan Hospital
Nov 8, 2023
Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of
Active, not recruiting
- Diabetic Nephropathy
- Grouping based on previous laboratory results, no intervention.
-
Jinan, Shandong, ChinaQianfoshan Hospital
Oct 24, 2023
The Clinical Relevance of Micro RNAs in Mild Traumatic Brain
Completed
- Brain Injuries, Traumatic
- Drawing of 7ml peripheral blood
-
Vienna, AustriaMedical University of Vienna
Dec 26, 2022
Epigenetic Silencing of MicroRNA for Predicting Therapeutic
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- Not interventional
-
Albuquerque, New MexicoUniversity of New Mexico - Cancer Center
Oct 4, 2022
Myocardial Infarction Registry
Recruiting
- Acute Coronary Syndrome
- no intervention is intended.
-
Heidelberg, Baden-Württemberg, GermanyUniversity Hospital of Heidelberg
Nov 13, 2023
Advanced and/or Metastatic Solid Tumours Trial in Groningen (Radiolabelled CB307, CB307)
Recruiting
- Advanced and/or Metastatic Solid Tumours
- Radiolabelled CB307
- CB307
-
Groningen, NetherlandsUniversity Medical Center Groningen,
Apr 28, 2023
28 Day Mortality Trial (no intervention)
Recruiting
- 28 Day Mortality
- no intervention
-
Nanjing, Jiangsu, ChinaZhongda Hospital, Southeast University
Nov 25, 2022
Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- +15 more
- Cisplatin
- +6 more
-
Los Angeles, California
- +1 more
Aug 5, 2022
microRNA in Erosive Hand Osteoarthritis and Psoriatic Arthritis
Completed
- Erosive Osteoarthritis
- Psoriatic Arthritis
- miRNA
-
Siena, ItalyRheumatology Unit Azienda Ospedaliera Universitaria Senese
Jan 4, 2023
The Long Non Coding MALAT1 asPotential Salivary Diagnostic
Completed
- Oral Cancer Biomarkers
-
Giza, EgyptRania Hassan Shalby
Jan 31, 2023
Peripheral Arterial Disease, Vascular Diseases, Peripheral, Arterial Occlusive Diseases Trial in San Antonio, Temple
Recruiting
- Peripheral Arterial Disease
- +3 more
- Revascularization operation
- Control group
-
San Antonio, Texas
- +1 more
Mar 3, 2022
Coronary Disease Trial in Wuhan (No intervention)
Enrolling by invitation
- Coronary Disease
- No intervention
-
Wuhan, Hubei, ChinaTongji Hospital
Oct 19, 2022
Cancer of Kidney, Kidney Cancer, Renal Cancer Trial in New York (124-Iodine-cG250 (124I-cG250))
Completed
- Cancer of Kidney
- +6 more
- 124-Iodine-cG250 (124I-cG250)
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Oct 3, 2022
Infiltrating Bladder Urothelial Carcinoma, Recurrent Bladder Carcinoma, Stage I Prostate Cancer Trial in Los Angeles (other,
Terminated
- Infiltrating Bladder Urothelial Carcinoma
- +9 more
- Cytology Specimen Collection Procedure
- +4 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 15, 2021